选择语言

Biotinylated Human GLP1R Full Length Protein, Flag Tag&His,Avitag™ (Detergent)

用户评价
货号-规格
价格
Qty.
GLR-H82D3-20ug
¥11340.00
GLR-H82D3-100ug
¥31500.00
合计0件 产品金额¥ 0

产品详情

  • 分子别名(Synonym)

    GLP-1-R, GLP-1R, glucagon like peptide 1 receptor

  • 表达区间及表达系统(Source)

    Biotinylated Human GLP1R Full Length Protein, Flag Tag&His,Avitag (GLR-H82D3) is expressed from human 293 cells (HEK293). It contains AA Arg 24 - Ser 432 (Accession # P43220-1).

    Predicted N-terminus: Asp

    Request for sequence
  • 蛋白结构(Molecular Characterization)

    GLP1R Structure

    This protein carries a Flag tag at the N-terminus and a polyhistidine tag at the C-terminus followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 67.9 kDa.

  • 偶联(Conjugate)

    Biotin

  • 标记(Labeling)

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • 内毒素(Endotoxin)

    Less than 1.0 EU per μg by the LAL method.

  • 纯度(Purity)

    90% as determined by SDS-PAGE.

  • 制剂(Formulation)

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • 运输(Shipping)

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • 存储(Storage)

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程
  • *The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow this link for product information.

产品展示

  • 活性(Bioactivity)-ELISA

     GLP1R ELISA

    Immobilized Biotinylated Human GLP1R Full Length Protein, Flag Tag&His,Avitag (Cat. No. GLR-H82D3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Glutazumab with a linear range of 0.06-2 ng/mL (QC tested).

    Protocol
  •  GLP1R ELISA

    Immobilized Biotinylated Human GLP1R Full Length Protein, Flag Tag&His,Avitag (Cat. No. GLR-H82D3) at 5 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Dulaglutide with a linear range of 0.5-31 ng/mL (Routinely tested).

    Protocol
  • 活性(Bioactivity)-SPR

     GLP1R SPR

    Dulaglutide captured on Protein A Chip can bind Biotinylated Human GLP1R Full Length Protein, Flag Tag&His,Avitag (Cat. No. GLR-H82D3) with an affinity constant of 1.91 µM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).

    Protocol
  •  GLP1R SPR

    Glutazumab captured on Protein A Chip can bind Biotinylated Human GLP1R Full Length Protein, Flag Tag&His,Avitag (Cat. No. GLR-H82D3) with an affinity constant of 30.6 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).

    Protocol

用户评价
发表评论

背景介绍

This gene encodes a 7-transmembrane protein that functions as a receptor for glucagon-like peptide 1 (GLP-1) hormone, which stimulates glucose-induced insulin secretion. This receptor, which functions at the cell surface, becomes internalized in response to GLP-1 and GLP-1 analogs, and it plays an important role in the signaling cascades leading to insulin secretion. It also displays neuroprotective effects in animal models. Polymorphisms in this gene are associated with diabetes. The protein is an important drug target for the treatment of type 2 diabetes and stroke.

前沿进展

 
药物研发进展
  • 英文全称:

    Glucagon-like peptide-1

  • 中文全称:

    胰高血糖素类肽-1

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    5 详情

  • 最高研发阶段:

    临床三期

联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价
  • 背景介绍